Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page
- CheckyesterdayChange DetectedA revision note shows the page version updated from v3.3.3 to v3.3.4, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedA new Locations section appears with Ontario as a site for the study. The footer shows Revision: v3.3.3 and removes the old Ontario Locations link as well as the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check51 days agoChange DetectedA new PubMed publication entry (Murugavel et al., 2025) was added to the Publications section, and the revision tag was updated to v3.3.2.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page no longer displays the government funding status banner (operating status notice). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedPublications section now lists a 2025 peer‑reviewed article (Murugavel et al., Diabetes Obes Metab) about the trial. The study record history has been updated to reflect this publication.SummaryDifference0.5%

- Check101 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference4%

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.